2,196 reports of this reaction
2.2% of all CONJUGATED ESTROGENS reports
#7 most reported adverse reaction
FATIGUE is the #7 most commonly reported adverse reaction for CONJUGATED ESTROGENS, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 2,196 FDA adverse event reports linking CONJUGATED ESTROGENS to FATIGUE. This represents approximately 2.2% of all 100,524 adverse event reports for this drug.
Patients taking CONJUGATED ESTROGENS who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for CONJUGATED ESTROGENS, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for CONJUGATED ESTROGENS:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,196 FDA reports for CONJUGATED ESTROGENS. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for CONJUGATED ESTROGENS, making it a notable side effect.
If you experience fatigue while taking CONJUGATED ESTROGENS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.